Efficacy and Safety of Oral Nicotinamide as an Adjunctive Therapy in Patients With Sepsis
NCT07655791
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Sepsis - to Reduce Mortality in the Intensive Care Unit
Interventions
DRUG:
Nicotinamide 1000 mg
Sponsor
Ain Shams University
Collaborators
[object Object]